1)Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S. 2012, The stability of toxigenicity in proteolytic Clostridium botulinum type B upon serial passage. Microbiol. Immunol., 56, 338-341.
2)Iritani N, Kaida A, Abe N. Sekiguchi J, Kubo H, Takakura K, Goto K, Ogura H, Seto Y. 2012, Increase of GII.2 Norovirus infection during the 2009-2010 season in Osaka city, Japan. J. Med. Virol., 84, 517-525.
3)Iritani N, Kaida A, Kubo H, Abe N, Goto K, Ogura H, Seto Y. 2010, Molecular epidemiology of Noroviruses detected in seasonal outbreaks of acute nonbacterial gastroenteritis in Osaka city, Japan, from 1996 – 1997 to 2008 – 2009. J. Med. Virol., 82: 2097-2105.
4)Umeda K,  Seto Y, Kohda T, Mukamoto M, Kozaki S. 2010, A novel multiplex PCR method for Clostridium botulinum neurotoxin type A gene cluster typing. Micro. Immunol. 54: 308-312.
5)Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S. 2009, Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J. Clin. Micro., 47:2720-2728
6)Iritani N, Vennema H, Siebenga JJ, Siezen RJ, Renckens B, Seto Y, Kaida A, Koopmans M. 2008. Genetic analysis of the capsid gene of genotype GII.2 noroviruses. J. Virol.,82:7339-7345.
7)Iritani N, Kaida A, Kubo H, Abe N, Murakami T, Vennema H, Koopmans M, Takeda N, Ogura H, Seto Y. 2008. An epidemic of GII.2 genotype noroviruses during the spring of 2004 in Osaka City, Japan. J. Clin. Micro., 46:2406-2409.
8)Iritani N, Seto T, Hattori H, Natori K, Takeda N, Kubo H, Yamano T, Ayata M, Ogura H, Seto Y. 2007.Humoral immune responses against norovirus infections of children. J. Med. Virol., 79:1187-1193.
9)Hansman G, Natori K, Shiratori-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N. 2006. Genetic and antigenetic diversity among noroviruses. J. Gen. Virol., 87:909-919.
10)Seto Y., Iritani N., Kubo H., Kaida A., Murakami T., Haruki K., Nishio O, Minoru A. and Ogura H. 2005. Genotyping of Norovirus strains detected between April 2002 and March 2003 in Osaka City, Japan. Microbiol. Immunol., 49:275-283.
11)Kamata K., Shinozaki K., Okada M., Seto Y., Kobayashi S., Sakae K., Oset M., Natori K., Horikosdi S. H., Katayama K., Tanaka T., Takeda N., and Taniguchi K. 2005. Expression and antigenicity of virus-like particles of Norovirus and their application for detection of Norovirus in stool samples. J. Med. Virol., 76:129-136.
12)Matsumoto M., Funai K., Tanabe M., Oshiumi H., Shingai M., Seto Y., Yamamoto A. and Seya T. 2004. Subcellular location of Toll-like receptor 3 in human dendritic cells. J Immunol., 171:3154-3162.
13)Ishida H., Ayata M., Shingai M., Matsunaga I., Seto Y., Katayama Y.,Iritani N., Seya T., Yanagi Y., Matsuoka O., Yamano T. and Ogura H. 2004. Infection of different cell lines of neural origin with subacute sclerosing panencephalitis. Microbiol. Immunol. 48:277-287.